[Salivary gland tumors in children]

Area of Science:

• Pediatric oncology
• Head and neck surgery
• Tumor pathology

Context:

• Salivary gland tumors represent 8-10% of pediatric head and neck tumors.
• Clinicians must consider these rare tumors in children presenting with non-inflammatory masses.
• Pediatric salivary gland tumors have a higher malignancy rate (50%) compared to adults (10-25%).

Purpose:

• To highlight the unique characteristics of pediatric salivary gland tumors.
• To emphasize the importance of prompt diagnosis and appropriate management strategies.
• To inform clinicians about the differential diagnosis and treatment options for these rare pediatric neoplasms.

Summary:

• Epithelial tumors are the most common type in children, with mucoepidermoid carcinomas of the parotid gland being particularly prevalent.
• Surgery is the primary treatment modality for epithelial salivary gland tumors.
• Adjuvant radiotherapy is considered for unfavorable prognostic factors, balancing benefits against risks of growth defects and secondary cancers. Chemotherapy has a limited role, reserved for unresectable or metastatic cases.

Impact:

• Increased awareness among clinicians can lead to earlier diagnosis and improved patient outcomes.
• Understanding the higher malignancy risk in children underscores the need for specialized pediatric care.
• This information aids in tailoring treatment strategies, optimizing surgical intervention, and judiciously applying adjuvant therapies to minimize long-term sequelae.